FIND OUT WHAT’S NEW AT EAGLE
TOP STORIES
- Eagle Pharmaceuticals Announces Acceptance of Two Abstracts at the Society for Academic Emergency Medicine (SAEM) Annual Meeting
- Eagle Pharmaceuticals Reports First Quarter 2023 Results
- Eagle Pharmaceuticals Granted Unique J-Code for Byfavo® (remimazolam for injection) from CMS
Read the latest from Eagle Pharmaceuticals
PURSUING
SCIENCE
TO HELP
PATIENTS
We discover, develop, and market medicines that matter to patients, healthcare providers, and health systems. We put science to work to serve a greater cause, helping patients and improving healthcare in the process.
OUR COLLECTIVE
COMMITMENT
Everything great starts with commitment. Our commitment to those whose lives are enriched by our products is unmatched. It fuels our ingenuity and passion for making a difference to patients, healthcare providers, and health systems.
HELPING
MEDICINES
DO MORE
A first-in-class new chemical entity (NCE) pipeline with promising product candidates that have the potential to help millions of patients across oncology and critical care.
THE SKY IS
THE LIMIT
Our strategic focus is to provide value for patients, healthcare providers, and health systems. We know that by doing so, we create value for all our stakeholders. The bottom line is that we believe our growing portfolio has the power to benefit everyone.
